Gastroenterology (all articles)
Non-alcoholic fatty liver disease: A patient guideline.
19 Sep, 2021 | 23:35h | UTCNon-alcoholic fatty liver disease: A patient guideline – JHEP Reports
Commentary on Twitter
Finally, here is a guideline specifically designed for patients with NAFLD 👍#4KMedEd #LiverTwitter
(Courtesy of @JHEP_Reports)https://t.co/wGTr50fMyE pic.twitter.com/5djcqKigeB
— Keith Siau (@drkeithsiau) September 19, 2021
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology.
17 Sep, 2021 | 10:11h | UTC
Guideline: Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome.
17 Sep, 2021 | 10:07h | UTC
Review | Functional gastrointestinal disorders: History taking skills in practice.
17 Sep, 2021 | 09:54h | UTCFunctional gastrointestinal disorders: History taking skills in practice – Clinical Medicine Journal
Review: Is there an optimal antiplatelet strategy after gastrointestinal bleeding in patients with coronary artery disease?
16 Sep, 2021 | 09:57h | UTC
State of the Art Review: Screening and prevention of colorectal cancer.
16 Sep, 2021 | 10:01h | UTCScreening and prevention of colorectal cancer – The BMJ (free for a limited period)
Related:
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Guidelines for the management of iron deficiency anemia in adults.
12 Sep, 2021 | 21:48h | UTC
Review: Cholangiocarcinoma.
10 Sep, 2021 | 05:02h | UTCCholangiocarcinoma – Nature Reviews Disease Primers (free for a limited period)
Infographic: Cholangiocarcinoma
Commentary on Twitter
Get Primed on #Cholangiocarcinoma with our NEW PrimeView! FREE to download this week! https://t.co/xw8yl29QI4 pic.twitter.com/JKtL6NqnlS
— Nature Reviews Disease Primers (@DiseasePrimers) September 9, 2021
Pancreatic Cancer: A Review.
9 Sep, 2021 | 08:51h | UTCPancreatic Cancer: A Review – JAMA (free for a limited period)
Defining pediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.
7 Sep, 2021 | 21:26h | UTCDefining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement – The Lancet Gastroenterology & Hepatology (free registration required)
Commentary on Twitter
New Viewpoint – Eslam et al – Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementhttps://t.co/YIW0DL7u5O#NAFLD #MAFLD #fattyliver #LiverTwitter @eslamm1222 pic.twitter.com/2AIHksqIgj
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) August 6, 2021
Antibiotics use is linked to increased risk of subsequent colorectal cancer.
7 Sep, 2021 | 21:25h | UTCCommentaries:
Antibiotics linked to increased risk of colon cancer – Umea University
Study links antibiotics use and increased subsequent risk of colorectal cancer – MedicalResearch.com
More data showing increased risk of hospitalization with SARS-CoV-2 delta variant.
6 Sep, 2021 | 11:12h | UTCHospitalisation associated with SARS-CoV-2 delta variant in Denmark – The Lancet Infectious Diseases
Podcast: The Best of Liver Tests.
7 Sep, 2021 | 10:29h | UTC#293 The Best of Liver Tests with Dr. Elliot Tapper – The Curbsiders
Position paper on the diagnosis and management of pediatric acute liver failure.
6 Sep, 2021 | 10:31h | UTC
M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.
2 Sep, 2021 | 08:14h | UTC
Commentary on Twitter
The long, winding and expensive road leading to highly sensitive and specific noninvasive Dx of #NASH @Gut_BMJ https://t.co/ToIkF3yTAU
— Daniel J Drucker (@DanielJDrucker) May 25, 2021
AGA clinical practice update on the diagnosis and management of atrophic gastritis.
1 Sep, 2021 | 09:45h | UTC
Commentary on Twitter
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis 👌🏻👌🏻@AGA_Gastro @AmerGastroAssn #GITwitter https://t.co/MihpPoVR2b pic.twitter.com/e3MJ6aIQML
— Eric Kauffman Ortega (@eric_kauff) August 26, 2021
Review: How to approach a patient with difficult-to-treat IBS.
27 Aug, 2021 | 09:00h | UTCHow to Approach a Patient with Difficult-to-Treat IBS – Gastroenterology (free for a limited period)
Commentary on Twitter
Happy to share 📰 on “How to Approach a Patient with Difficult to Treat IBS” in @AGA_Gastro.
Diagnostic algorithm, practical tips, meds & doses. Based on scientific data & what I've learned caring for #IBS pts for many years.
Free for next 50 days 👉 https://t.co/pHKvJuhZtg
— Lin Chang (@LinChangMD) August 25, 2021
A review of the epidemiology, pathophysiology, and efficacy of anti-diabetic drugs used in the treatment of nonalcoholic fatty liver disease.
27 Aug, 2021 | 08:59h | UTC
AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases.
25 Aug, 2021 | 08:48h | UTC
AGA clinical practice update on evaluation and management of early complications after bariatric/metabolic surgery.
24 Aug, 2021 | 09:02h | UTC
Commentary on Twitter
August's Essential Reading article is a Clinical Practice Update on evaluation and management of early complications after bariatric/metabolic surgery @AmerGastroAssn https://t.co/mm8qSkR95y pic.twitter.com/6vsI3qGv2I
— CGH (@AGA_CGH) July 28, 2021
Guideline for immunizations in patients with inflammatory bowel disease.
24 Aug, 2021 | 09:00h | UTC
European guidelines on microscopic colitis.
24 Aug, 2021 | 08:58h | UTC
Cohort study: Association of incomplete polyp removal with risk of postcolonoscopy colorectal cancer.
17 Aug, 2021 | 08:43h | UTCOriginal study: Recurrence of Colorectal Neoplastic Polyps After Incomplete Resection – Annals of Internal Medicine (link to abstract – $ for full-text)
AGA clinical practice update on strategies to improve quality of screening and surveillance colonoscopy.
16 Aug, 2021 | 01:01h | UTC
Commentary on Twitter
https://twitter.com/AEspinoChile/status/1421634001672998920
Guideline: Acute abdomen in the immunocompromised patient.
16 Aug, 2021 | 01:00h | UTC